The 36-month beta value for LFST is at 1.21. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 4 as “hold,” and 1 as “sell.”
The public float for LFST is 111.27M, and currently, shorts hold a 10.90% of that float. The average trading volume for LFST on September 18, 2024 was 1.63M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
LFST) stock’s latest price update
The stock of LifeStance Health Group Inc (NASDAQ: LFST) has increased by 0.95 when compared to last closing price of 6.83.Despite this, the company has seen a gain of 2.30% in its stock price over the last five trading days. globenewswire.com reported 2024-09-12 that TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support human wellness in innovative ways, is pleased to report that, further to its news release dated June 25, 2024, it has completed the sale today of the shares (the “Closing”) of CannMart Inc. (“CannMart”), a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, to Simply Solventless Concentrates Ltd.
LFST’s Market Performance
LFST’s stock has risen by 2.30% in the past week, with a monthly rise of 18.67% and a quarterly rise of 30.34%. The volatility ratio for the week is 3.70% while the volatility levels for the last 30 days are 4.18% for LifeStance Health Group Inc The simple moving average for the last 20 days is 5.80% for LFST’s stock, with a simple moving average of 9.12% for the last 200 days.
Analysts’ Opinion of LFST
Many brokerage firms have already submitted their reports for LFST stocks, with Barclays repeating the rating for LFST by listing it as a “Underweight.” The predicted price for LFST in the upcoming period, according to Barclays is $7 based on the research report published on January 03, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see LFST reach a price target of $9, previously predicting the price at $8. The rating they have provided for LFST stocks is “Market Perform” according to the report published on May 15th, 2023.
Morgan Stanley gave a rating of “Overweight” to LFST, setting the target price at $8 in the report published on January 06th of the previous year.
LFST Trading at 15.99% from the 50-Day Moving Average
After a stumble in the market that brought LFST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.05% of loss for the given period.
Volatility was left at 4.18%, however, over the last 30 days, the volatility rate increased by 3.70%, as shares surge +20.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +34.90% upper at present.
During the last 5 trading sessions, LFST rose by +2.08%, which changed the moving average for the period of 200-days by +0.15% in comparison to the 20-day moving average, which settled at $6.57. In addition, LifeStance Health Group Inc saw -11.94% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFST starting from KHAN IRREVOCABLE TRUST LLC, who proposed sale 87,830 shares at the price of $6.94 back on Sep 13 ’24. After this action, KHAN IRREVOCABLE TRUST LLC now owns shares of LifeStance Health Group Inc, valued at $609,540 using the latest closing price.
Varanakis Ann, the Chief People Officer of LifeStance Health Group Inc, sale 5,269 shares at $6.28 during a trade that took place back on Aug 23 ’24, which means that Varanakis Ann is holding 263,007 shares at $33,089 based on the most recent closing price.
Stock Fundamentals for LFST
Current profitability levels for the company are sitting at:
- -0.12 for the present operating margin
- 0.25 for the gross margin
The net margin for LifeStance Health Group Inc stands at -0.13. The total capital return value is set at -0.07. Equity return is now at value -10.32, with -7.04 for asset returns.
Based on LifeStance Health Group Inc (LFST), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -6.07.
Currently, EBITDA for the company is -106.91 million with net debt to EBITDA at -7.48. When we switch over and look at the enterprise to sales, we see a ratio of 2.6. The receivables turnover for the company is 6.91for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.22.
Conclusion
In conclusion, LifeStance Health Group Inc (LFST) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
